175 related articles for article (PubMed ID: 18501462)
1. Modulation of microenvironmental pH and crystallinity of ionizable telmisartan using alkalizers in solid dispersions for controlled release.
Tran PH; Tran HT; Lee BJ
J Control Release; 2008 Jul; 129(1):59-65. PubMed ID: 18501462
[TBL] [Abstract][Full Text] [Related]
2. Roles of MgO release from polyethylene glycol 6000-based solid dispersions on microenvironmental pH, enhanced dissolution and reduced gastrointestinal damage of telmisartan.
Tran PH; Tran TT; Lee SA; Nho VH; Chi SC; Lee BJ
Arch Pharm Res; 2011 May; 34(5):747-55. PubMed ID: 21656360
[TBL] [Abstract][Full Text] [Related]
3. Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique.
Marasini N; Tran TH; Poudel BK; Cho HJ; Choi YK; Chi SC; Choi HG; Yong CS; Kim JO
Int J Pharm; 2013 Jan; 441(1-2):424-32. PubMed ID: 23174408
[TBL] [Abstract][Full Text] [Related]
4. Enhanced gastric stability of esomeprazole by molecular interaction and modulation of microenvironmental pH with alkalizers in solid dispersion.
Van Nguyen H; Baek N; Lee BJ
Int J Pharm; 2017 May; 523(1):189-202. PubMed ID: 28342789
[TBL] [Abstract][Full Text] [Related]
5. Dissolution-modulating mechanism of alkalizers and polymers in a nanoemulsifying solid dispersion containing ionizable and poorly water-soluble drug.
Tran TT; Tran PH; Lee BJ
Eur J Pharm Biopharm; 2009 May; 72(1):83-90. PubMed ID: 19141319
[TBL] [Abstract][Full Text] [Related]
6. Investigation of physicochemical factors affecting the stability of a pH-modulated solid dispersion and a tablet during storage.
Tran PH; Tran TT; Park JB; Min DH; Choi HG; Han HK; Rhee YS; Lee BJ
Int J Pharm; 2011 Jul; 414(1-2):48-55. PubMed ID: 21565260
[TBL] [Abstract][Full Text] [Related]
7. Dissolution-enhancing mechanism of alkalizers in poloxamer-based solid dispersions and physical mixtures containing poorly water-soluble valsartan.
Ha NS; Tran TT; Tran PH; Park JB; Lee BJ
Chem Pharm Bull (Tokyo); 2011; 59(7):844-50. PubMed ID: 21720034
[TBL] [Abstract][Full Text] [Related]
8. Influence of alkalizers on dissolution properties of telmisartan in solid dispersions prepared by cogrinding.
Zhong L; Zhu X; Yu B; Su W
Drug Dev Ind Pharm; 2014 Dec; 40(12):1660-9. PubMed ID: 24099550
[TBL] [Abstract][Full Text] [Related]
9. Dissolution properties and physical characterization of telmisartan-chitosan solid dispersions prepared by mechanochemical activation.
Zhong L; Zhu X; Luo X; Su W
AAPS PharmSciTech; 2013 Jun; 14(2):541-50. PubMed ID: 23430728
[TBL] [Abstract][Full Text] [Related]
10. Modulation of microenvironmental pH and utilization of alkalizers in crystalline solid dispersion for enhanced solubility and stability of clarithromicin.
Park JB; Park YJ; Kang CY; Lee BJ
Arch Pharm Res; 2015; 38(5):839-48. PubMed ID: 25213008
[TBL] [Abstract][Full Text] [Related]
11. Development of prednisone:polyethylene glycol 6000 fast-release tablets from solid dispersions: solid-state characterization, dissolution behavior, and formulation parameters.
Leonardi D; Barrera MG; Lamas MC; Salomón CJ
AAPS PharmSciTech; 2007 Dec; 8(4):E108. PubMed ID: 18181529
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of telmisartan tablets prepared via the wet granulation method and pritor™ prepared using the spray-drying method.
Park J; Park HJ; Cho W; Cha KH; Yeon W; Kim MS; Kim JS; Hwang SJ
Arch Pharm Res; 2011 Mar; 34(3):463-8. PubMed ID: 21547679
[TBL] [Abstract][Full Text] [Related]
13. Design of fixed dose combination and physicochemical characterization of enteric-coated bilayer tablet with circadian rhythmic variations containing telmisartan and pravastatin sodium.
Luo D; Kim JH; Park C; Oh E; Park JB; Cui JH; Cao QR; Lee BJ
Int J Pharm; 2017 May; 523(1):343-356. PubMed ID: 28330645
[TBL] [Abstract][Full Text] [Related]
14. Crystallinity evaluation of tacrolimus solid dispersions by chemometric analysis.
Zidan AS; Rahman Z; Sayeed V; Raw A; Yu L; Khan MA
Int J Pharm; 2012 Feb; 423(2):341-50. PubMed ID: 22100517
[TBL] [Abstract][Full Text] [Related]
15. Tannate complexes of antihistaminic drug: sustained release and taste masking approaches.
Rahman Z; Zidan AS; Berendt RT; Khan MA
Int J Pharm; 2012 Jan; 422(1-2):91-100. PubMed ID: 22037447
[TBL] [Abstract][Full Text] [Related]
16. Inclusion of telmisartan in mesocellular foam nanoparticles: drug loading and release property.
Zhang Y; Jiang T; Zhang Q; Wang S
Eur J Pharm Biopharm; 2010 Sep; 76(1):17-23. PubMed ID: 20685333
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying.
Parikh T; Sandhu HK; Talele TT; Serajuddin AT
Pharm Res; 2016 Jun; 33(6):1456-71. PubMed ID: 26951566
[TBL] [Abstract][Full Text] [Related]
18. Investigation and correlation of physical stability, dissolution behaviour and interaction parameter of amorphous solid dispersions of telmisartan: a drug development perspective.
Dukeck R; Sieger P; Karmwar P
Eur J Pharm Sci; 2013 Jul; 49(4):723-31. PubMed ID: 23684913
[TBL] [Abstract][Full Text] [Related]
19. Physicochemical characterisation, drug polymer dissolution and in vitro evaluation of phenacetin and phenylbutazone solid dispersions with polyethylene glycol 8000.
Khan S; Batchelor H; Hanson P; Perrie Y; Mohammed AR
J Pharm Sci; 2011 Oct; 100(10):4281-94. PubMed ID: 21560130
[TBL] [Abstract][Full Text] [Related]
20. pH-responsive polymeric micelles of poly(ethylene glycol)-b-poly(alkyl(meth)acrylate-co-methacrylic acid): influence of the copolymer composition on self-assembling properties and release of candesartan cilexetil.
Satturwar P; Eddine MN; Ravenelle F; Leroux JC
Eur J Pharm Biopharm; 2007 Mar; 65(3):379-87. PubMed ID: 17123802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
